OTCMKTS:DNPUF

Sumitomo Dainippon Pharma Stock Forecast, Price & News

$17.40
0.00 (0.00 %)
(As of 04/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$17.40
Now: $17.40
$17.40
50-Day Range
$16.50
MA: $17.53
$18.75
52-Week Range
$12.45
Now: $17.40
$18.75
VolumeN/A
Average Volume978 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, diagnostics, and others. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, depression, type 2 diabetes, systemic fungal infection, pruritus, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia. It also provides atypical antipsychotic, antiepileptic, carbapenem antibiotic, and gastroprokine products; and Anderson-Fabry disease drugs. In addition, the company offers food ingredients and additives, such as polysaccharides, and seasonings, such as soups or bouillons; and chemical product materials consisting of pharmaceutical excipients, personal care products, coatings and industrial materials, and electronic materials. Further, it provides veterinary medicines for companion animals, primarily dogs and cats; and livestock comprising cattle, swine, poultry, horses, and aquacultured fish. Sumitomo Dainippon Pharma Co., Ltd. has partnerships with Healios K.K.; Keio University; RIKEN; the Center for iPS Cell Research and Application (CiRA); Kyoto University; and Aikomi Co., Ltd., as well as a joint development agreement with SanBio, Inc. It also has a strategic research collaboration agreement with Gain Therapeutics, Inc. for the research and development of structurally targeted allosteric regulators to restore functional activity of defective lysosomal enzymes in rare genetic and demyelinating diseases. The company was formerly known as Dainippon Sumitomo Pharma Co., Ltd. and changed its name to Sumitomo Dainippon Pharma Co., Ltd. in June 2014. Sumitomo Dainippon Pharma Co., Ltd. was founded in 1897 and is headquartered in Osaka, Japan. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:DNPUF
CUSIPN/A
CIKN/A
Phone81 6 6203 5321
Employees6,457
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Headlines

Here's what to expect from Sumitomo Dainippon Pharma's earnings
January 26, 2021 |  markets.businessinsider.com
See More Headlines

MarketRank

Overall MarketRank

0.52 out of 5 stars

Medical Sector

1524th out of 2,021 stocks

Drug Manufacturers - Specialty & Generic Industry

44th out of 61 stocks

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$17.40
0.00 (0.00 %)
(As of 04/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DNPUF News and Ratings via Email

Sign-up to receive the latest news and ratings for DNPUF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sumitomo Dainippon Pharma (OTCMKTS:DNPUF) Frequently Asked Questions

What stocks does MarketBeat like better than Sumitomo Dainippon Pharma?

Wall Street analysts have given Sumitomo Dainippon Pharma a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Sumitomo Dainippon Pharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Sumitomo Dainippon Pharma?

Sumitomo Dainippon Pharma saw a decrease in short interest in March. As of March 15th, there was short interest totaling 815,100 shares, a decrease of 59.3% from the February 28th total of 2,002,300 shares. Based on an average daily volume of 300 shares, the short-interest ratio is presently 2,717.0 days.
View Sumitomo Dainippon Pharma's Short Interest
.

How has Sumitomo Dainippon Pharma's stock been impacted by COVID-19?

Sumitomo Dainippon Pharma's stock was trading at $14.80 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, DNPUF stock has increased by 17.6% and is now trading at $17.40.
View which stocks have been most impacted by COVID-19
.

Who are Sumitomo Dainippon Pharma's key executives?

Sumitomo Dainippon Pharma's management team includes the following people:
  • Mr. Hiroshi Nomura, CEO, Pres & Representative Director (Age 64)
  • Hisayoshi Kashima, Sr. Director & Corp. Controller
  • Mr. Toru Kimura Ph.D., Exec. VP, Chief Scientific Officer & Representative Director (Age 61)
  • Ms. Atsuko Higuchi, Exec. Officer of Corp. Governance, Corp. Communications & HR
  • Mr. Hitoshi Odagiri, Exec. VP, Exec. Director of Sales & Mktg. Div., Head of Japan Bus. Unit and Rep. Director (Age 64)
  • Mr. Yoshiharu Ikeda Ph.D., Sr. Exec. Officer & Director (Age 63)
  • Mr. Hiroyuki Baba, Sr. Exec. Officer of Global Data Design Office
  • Dr. Shigeyuki Nishinaka Ph.D., Sr. Exe. Officer of Global Corp. Strategy, Global Bus. Dev. & International Bus. Mgmt (Age 56)
  • Mr. Hideyuki Harada, Sr. Exec. Officer & Exec. Research Director of Drug Research Division
  • Tetsuya Uyama, Sr. Officer of Legal Disputes

Who are some of Sumitomo Dainippon Pharma's key competitors?

What is Sumitomo Dainippon Pharma's stock symbol?

Sumitomo Dainippon Pharma trades on the OTCMKTS under the ticker symbol "DNPUF."

How do I buy shares of Sumitomo Dainippon Pharma?

Shares of DNPUF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sumitomo Dainippon Pharma's stock price today?

One share of DNPUF stock can currently be purchased for approximately $17.40.

How many employees does Sumitomo Dainippon Pharma have?

Sumitomo Dainippon Pharma employs 6,457 workers across the globe.

What is Sumitomo Dainippon Pharma's official website?

The official website for Sumitomo Dainippon Pharma is www.ds-pharma.com.

How can I contact Sumitomo Dainippon Pharma?

The company can be reached via phone at 81 6 6203 5321.


This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.